These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23083053)

  • 1. Pattern of skin thickness progression and clinical correlation in Thai scleroderma patients.
    Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Int J Rheum Dis; 2012 Oct; 15(5):e90-5. PubMed ID: 23083053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
    Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report).
    Foocharoen C; Pussadhamma B; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Rheumatology (Oxford); 2015 Sep; 54(9):1616-21. PubMed ID: 25863044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China.
    Zhang SZ; Xu D; Li MT; Hou Y; Wang Q; Tian Z; Liu YT; Guo XX; Lai JZ; Zhao JL; Hu CJ; Song N; Sun QN; Zhang FC; Zhao Y; Zeng XF
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S106-10. PubMed ID: 26005882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model.
    Shand L; Lunt M; Nihtyanova S; Hoseini M; Silman A; Black CM; Denton CP
    Arthritis Rheum; 2007 Jul; 56(7):2422-31. PubMed ID: 17599771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study.
    Tipparot T; Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Nanagara R; Pussadhamma B; Chaosuwannakit N
    Int J Rheum Dis; 2019 Dec; 22(12):2125-2133. PubMed ID: 31659856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.
    Vanthuyne M; Smith V; De Langhe E; Van Praet J; Arat S; Depresseux G; Westhovens R; Blockmans D; Badot V; Cogan E; De Keyser F; Houssiau FA
    J Rheumatol; 2012 Nov; 39(11):2127-33. PubMed ID: 22984273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assessment of skin tightness severity by scleroderma patients.
    Daungkum K; Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Thinkhamrop B; Nanagara R
    Int J Rheum Dis; 2016 Oct; 19(10):989-995. PubMed ID: 27126197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatology life quality index in Thai patients with systemic sclerosis: a cross-sectional study.
    Chularojanamontri L; Sethabutra P; Kulthanan K; Manapajon A
    Indian J Dermatol Venereol Leprol; 2011; 77(6):683-7. PubMed ID: 22016275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis.
    Netwijitpan S; Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Clin Rheumatol; 2013 Mar; 32(3):361-7. PubMed ID: 23224269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients.
    Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Clin Rheumatol; 2011 Sep; 30(9):1235-40. PubMed ID: 21484224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.
    Clements P; Lachenbruch P; Siebold J; White B; Weiner S; Martin R; Weinstein A; Weisman M; Mayes M; Collier D
    J Rheumatol; 1995 Jul; 22(7):1281-5. PubMed ID: 7562759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and disease outcomes of undifferentiated arthritis in Thailand.
    Foocharoen C; Nanagara R; Suwannaroj S; Mahakkanukrauh A
    Int J Rheum Dis; 2011 Aug; 14(3):e14-21. PubMed ID: 21816008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort.
    Marangoni RG; Rocha LF; Del Rio AP; Yoshinari NH; Marques-Neto JF; Sampaio-Barros PD
    Rheumatology (Oxford); 2013 Aug; 52(8):1520-4. PubMed ID: 23661427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study.
    Matsuda KM; Yoshizaki A; Kuzumi A; Fukasawa T; Ebata S; Miura S; Toyama T; Yoshizaki A; Sumida H; Asano Y; Oba K; Sato S
    Arthritis Res Ther; 2019 May; 21(1):129. PubMed ID: 31138286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.